NCT04779671

Brief Summary

Mild cognitive impairment (MCI) and subjective cognitive decline (SCD) are risk groups for dementia, and thus appropriate interventions are required. Cognitive training is a common intervention applied to the elderly with cognitive decline. Cognitive training integrated into leisure activities can increase the training motivation of the elderly, while improving cognitive performance and daily functions. Virtual reality (VR) can simulate daily living situations, and it can be an effective intervention with cognitive training. Although a few studies have found immersive VR cognitive training can improve the cognitive function of the elderly with cognitive decline, these studies have shown inconsistent results. In addition, it is yet not clear the long-term effect of fully immersive VR cognitive training and its impact on daily function. Furthermore, for immersive VR cognitive training, there is still a lack of training programs that integrate into the context of leisure activities. This type of VR cognitive training could help the effectiveness of cognitive training to be transferred into daily functions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
190

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

May 17, 2021

Status Verified

May 1, 2021

Enrollment Period

2.8 years

First QC Date

March 1, 2021

Last Update Submit

May 13, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change scores of the Montreal Cognitive Assessment (MoCA)

    The Montreal Cognitive Assessment (MoCA) was designed as a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Time to administer the MoCA is approximately 10 minutes. The total possible score is 30 points; a score of 26 or above is considered normal.

    baseline, posttest (around 12 weeks after baseline)

  • Change scores of the Wechsler Memory Scale - Third Edition (WMS-III)

    Several subtests of Wechsler Memory Scale - Third Edition (WMS-III) including Faces Recognition (total scale=48), Verbal Paired Associates (total scale = 32), Word Lists (total scale = 48), and Spatial Span (total scale=32) will be used to assess the immediate, delayed, and working memory tests. For each subtest, a higher number indicates better performance in memory function. The raw score of subtests will also be transferred to standardized Z scores and summed to represent an index of general memory function.

    baseline, posttest (around 12 weeks after baseline)

  • Change scores of Stroop Color-Word Test

    The Stroop Color-Word test assesses the abilities of selective attention, inhibition and executive function. The participants will be tested under congruent and incongruent conditions. In the congruent condition, the participant will name the color ink of a word which is consistent with the written color name; whereas in the incongruent condition the participant will name the color ink differs from the written color name. In both conditions, the number of colors correctly named within 45 seconds will be measured and the performance in the congruent condition will be compared with the incongruent condition.

    baseline, posttest (around 12 weeks after baseline)

Secondary Outcomes (6)

  • Change scores of the Wechsler Adult Intelligence Scale (WAIS)

    baseline, posttest (around 12 weeks after baseline)

  • Change scores of the Everyday Cognition scales (ECog)-12 items

    baseline, posttest (around 12 weeks after baseline)

  • Change scores of the Lawton Instrumental Activities of Daily Living Scale (IADL)

    baseline, posttest (around 12 weeks after baseline)

  • Change scores of the WHOQOL-BREF Taiwan Version

    baseline, posttest (around 12 weeks after baseline)

  • Change scores of Geriatric Depression Scale (GDS)

    baseline, posttest (around 12 weeks after baseline)

  • +1 more secondary outcomes

Study Arms (2)

VR group

EXPERIMENTAL
Behavioral: VR cognitive training

control group

ACTIVE COMPARATOR
Behavioral: Traditional cognitive training

Interventions

All participants will receive trainings for 60 minutes per day, two days per week for 16 sessions. They will receive one immersive leisure-based VR cognitive training for 30 minutes. VR cognitive training receives four gardening activities. The cognitive elements including attention, working memory, processing speed, and executive function incorporated training.

VR group

All participants will receive trainings for 60 minutes per day, two days per week for 16 sessions. The control group is performing traditional cognitive training program.

control group

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age range from 60 to 90 years
  • self- or informant-reported memory or cognitive complaint.
  • able to follow instruction
  • MMSE score \<26
  • dose not have dementia.
  • age range from 60 to 90 years;
  • MMSE\>=26;
  • ECog-12 score \>1;
  • does not conform the standards of MCI and dementia .

You may not qualify if:

  • dizziness or epilepsy history;
  • neurological or other orthopedic diseases with neurological or other orthopedic diseases unstable physical condition of VR cognitive training;
  • Recent psychiatric diagnosis, such as depression.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung University

Taoyuan District, 333, Taiwan

RECRUITING

Study Officials

  • I-Ching Chuan, Ph.D

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

I-Ching Chuang, Ph.D

CONTACT

Ching-yi Wu, ScD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2021

First Posted

March 3, 2021

Study Start

October 1, 2021

Primary Completion

July 1, 2024

Study Completion

July 1, 2024

Last Updated

May 17, 2021

Record last verified: 2021-05

Locations